If you're seeing this message, that means
JavaScript has been disabled on your browser
, please
enable JS
to make this app work.
No tags found
Companies
No companies found
Advanced Search
Newsfeed
Alerts
Saved Lists
Sign Up for Free
Login
Update this Profile
Get Updates
3
Followers on Owler
Tychon Bioscience
discovers and develops prosthetic antigen receptors for oncolytic immunotherapy...
Read more
Overview
Funding
News & Insights
Tychon Bioscience
discovers and develops prosthetic antigen receptors for oncolytic immunotherapy...
Read more
CEO
Add
CEO Approval Rating
- -/100
2014
Minneapolis
Minnesota
Twin Cities
Private
Add Industry
Add Sector
http://tychonbio.com
Est. Annual Revenue
<$1M
Agree?
Yes
No
Est. Employees
<10
Agree?
Yes
No
Funding
$670.7K
News
Latest News
Nov 25, 2015
MedCity News
Tychon Bioscience: Startup's alternative to CAR-T immunotherapy: PAR-T
Follow and Get Alerts
Trending Companies
